Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL
Clinical trial NCT03820596 · COMPLETED
Trial details
- NCT number
- NCT03820596
- Sponsor
- Huiqiang Huang
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2020-05-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.